Q301--Genotyping, Long-Read Sequencing, and Annotation
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA) has awarded a Firm Fixed Price Indefinite Delivery Indefinite Quantity (IDIQ) contract to Infinity Biologix LLC for Genotyping, Long-Read Sequencing, and Annotation services. This sole source award ensures critical support for the Million Veteran Program (MVP) under the Genomic Medicine Program.
Scope of Work
The contract covers essential services including large-scale protein variant screening, long-read sequencing for complex structural variations, comprehensive proteomic surveys, and detailed peptide mapping. Key deliverables involve maintaining molecular assay specificity, reproducibility, and data accuracy, processing large sample volumes efficiently, and delivering fully annotated results with quality metrics and metadata. This includes processing coded human samples, quality control, long-read sequencing, proteomics analyses, and gene expression profiling.
Contract & Timeline
- Contract Type: Firm Fixed Price IDIQ
- Awardee: Infinity Biologix LLC
- Period of Performance: Ordering period from September 30, 2025, to September 29, 2030.
- Value: Not explicitly stated in the provided document, referenced in a redacted section.
- Set-Aside: Other Than Full and Open Competition (Sole Source).
- Notice Published: February 27, 2026.
Evaluation
This procurement was conducted as a sole source award under statutory authority 41 USC §3304(a)(1), citing only one responsible source. Market research indicated that the "Rule of Two" for Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) and Veteran-Owned Small Businesses (VOSBs) could not be met for vendors specializing in bioinformatics. An intent to sole source was previously posted, and no responses were received from industry.
Additional Notes
Infinity Biologix LLC is an established partner with demonstrated, reliable, and validated capabilities. Transitioning to a new vendor would require significant re-development and validation efforts, estimated at approximately 10,000 hours of lab and data science effort, and would risk batch-to-batch continuity. The previous contract was 36C24E20D0028.